The constipating effect of diphenoxylate (Retardinr) in ulcerative colitis. A double-blind controlled trial.

Author: BinderV, EngbaekJ, ErsböllJ, FaurbyV, RiisP

Paper Details 
Original Abstract of the Article :
A double-blind study of 20 patients with ulcerative colitis during treatment with diphenoxylate 5 mg three times daily and placebo is reported. There were two treatment periods of 14 days each, with cross-over technique and randomized sequence. Test variable for constipating effect was the mean numb...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/1103271

データ提供:米国国立医学図書館(NLM)

Constipation in Ulcerative Colitis: Diphenoxylate's Effect

In the vast desert of gastrointestinal research, we often encounter the thorny issue of constipation in ulcerative colitis. This study digs deep into the sands to explore the effects of diphenoxylate, a medication commonly used for diarrhea. The researchers used a double-blind, controlled trial involving 20 patients with ulcerative colitis. They carefully monitored their bowel movements during two treatment periods, each lasting 14 days, switching between diphenoxylate and a placebo. The key finding was a significant reduction in the number of bowel movements, leading to constipation, during the diphenoxylate treatment period. This effect was observed both in the initial 12-day period and the subsequent 6-day period. However, the researchers noted that diphenoxylate also caused side effects in a significant proportion of the participants. This observation led them to conclude that diphenoxylate, despite its constipating effects, is not a suitable option for the routine treatment of ulcerative colitis.

Diphenoxylate - A Double-Edged Sword

This study highlights the delicate balance between intended and unintended effects of medications. Diphenoxylate, while successfully reducing bowel movements, unfortunately comes with the cost of side effects. This finding emphasizes the importance of personalized medicine, where treatment choices are tailored to each individual's unique needs and responses.

Managing Ulcerative Colitis: A Holistic Approach

The study emphasizes the importance of seeking alternative approaches for managing ulcerative colitis. This may involve exploring various treatment options, lifestyle modifications, and complementary therapies like mindfulness or yoga, all aimed at minimizing potential side effects and maximizing patient well-being.

Dr. Camel's Conclusion

Just like a camel navigating a treacherous desert, managing ulcerative colitis requires a cautious and informed approach. This study serves as a reminder to be mindful of potential side effects and to seek alternative solutions for a holistic approach to health. It's not just about the medication, but also about the entire journey towards wellness.

Date :
  1. Date Completed 1976-01-16
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

1103271

DOI: Digital Object Identifier

1103271

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.